Disc Medicine Q2 EPS $(1.54) Beats $(1.77) Estimate

Benzinga · 2d ago
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.54) per share which beat the analyst consensus estimate of $(1.77) by 12.99 percent. This is a 2.53 percent increase over losses of $(1.58) per share from the same period last year.